optimizing cns prophylaxis in the treatment of all
Published 7 months ago • 57 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:16
the optimization of induction chemotherapy for patients with aml
-
1:11
the treatment of aml within the united kingdom nhs framework
-
2:42
optimizing biological agents for all
-
0:58
management strategies for acute and chronic gvhd following allosct
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:51
checkpoint inhibition in the treatment of mpns
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
5:54
treating intermediate/high-risk primary myelofibrosis
-
9:25
mgus diagnosis: a step-by-step approach
-
2:57
novel targeted therapies for the treatment of bpdcn
-
2:42
optimizing maintenance therapy in multiple myeloma: an analysis from the preamble registry
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
2:09
advances in the management of fit adults with aml
-
1:01
latest advances in myelofibrosis treatment
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
1:36
chemotherapy and allohsct in the treatment of all
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl